Incannex Healthcare IXHL
NASDAQ IXHL
$3.35 -0.02 (-0.59%)
As of: Sep 9, 2026 · 1:52 PM EDT

Incannex Healthcare (IXHL) Non-Current Assets (2022 - 2026)

Incannex Healthcare's (IXHL) quarterly Non-Current Assets came in at $188000.0 in Q1 2026, down 66.9% year-over-year from $568000.0 in Q1 2025, and down 42.68% quarter-over-quarter from $328000.0 in Q4 2025.

Analysis

Incannex Healthcare (IXHL) Non-Current Assets (2022 - 2026) Analysis & Trends

Incannex Healthcare has disclosed Non-Current Assets across 5 years of filings, most recently posting $188000.0 for Q1 2026.

  • In Q1 2026, Non-Current Assets fell 66.9% year-over-year to $188000.0; the TTM figure through Mar 2026 stood at $1.4 million (down 50.04% YoY), while the FY2025 annual figure was $485000.0, down 42.6% from the prior year.
  • Non-Current Assets came in at $188000.0 for Q1 2026 at Incannex Healthcare, down from $328000.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $53.1 million in Q4 2022 to a low of $188000.0 in Q1 2026.
  • Average Non-Current Assets over 5 years is $5.0 million, with a median of $694000.0 recorded in 2023.
  • Year-over-year, Non-Current Assets plunged 98.07% in 2023 and climbed 7.51% in 2024.
  • Over 5 years, Non-Current Assets stood at $53.1 million in 2022, then sank by 98.07% to $1.0 million in 2023, then slumped by 41.38% to $602000.0 in 2024, then tumbled by 45.51% to $328000.0 in 2025, then slumped by 42.68% to $188000.0 in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $188000.0 in Q1 2026, $328000.0 in Q4 2025, and $425000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 646.53 Bn 625.77 Bn 17.26 Bn 141.29 Bn
2 AbbVie 442.27 Bn 435.70 Bn 12.70 Bn 101.45 Bn
3 Merck 366.81 Bn 359.67 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn 94.68 Bn
5 Pfizer 159.37 Bn 147.67 Bn 10.94 Bn 159.77 Bn
6 Sanofi 52.46 Bn 45.08 Bn 10.79 Bn 113.37 Bn
7 Revolution Medicines 44.12 Bn 44.12 Bn - 294.93 Mn
8 Incyte 25.49 Bn 20.95 Bn 1.57 Bn 1.85 Bn
9 United Therapeutics 21.55 Bn 18.89 Bn 683.80 Mn 3.74 Bn
10 Incannex Healthcare 41.37 Mn 41.37 Mn - 188,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 188,000.00
Dec 31, 2025 328,000.00
Sep 30, 2025 425,000.00
Jun 30, 2025 485,000.00
Mar 31, 2025 568,000.00
Dec 31, 2024 602,000.00
Sep 30, 2024 839,000.00
Jun 30, 2024 845,000.00
Mar 31, 2024 931,000.00
Dec 31, 2023 1.03 Mn
Jun 30, 2023 786,000.00
Dec 31, 2022 53.09 Mn